- Home
- BMI vs INDV Comparison
BMI vs INDV Comparison
Compare BMI & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMI | INDV |
|---|---|---|
| Founded | 1905 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.4B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BMI | INDV |
|---|---|---|
| Price | $127.99 | $40.03 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $170.13 | N/A |
| AVG Volume (30 Days) | 514.9K | ★ 1.5M |
| Earning Date | 04-17-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | 13.24 | ★ 8100.00 |
| EPS | ★ 1.95 | 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $5.97 | N/A |
| Revenue Next Year | $7.17 | N/A |
| P/E Ratio | $64.78 | ★ $58.73 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $112.09 | $16.99 |
| 52 Week High | $204.00 | $42.81 |
Technical Indicators
Market Signals| Indicator | BMI | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 39.56 | 53.44 |
| Support Level | $127.34 | $39.20 |
| Resistance Level | $154.15 | $41.42 |
| Average True Range (ATR) | 6.31 | 1.28 |
| MACD | -2.96 | -0.14 |
| Stochastic Oscillator | 20.41 | 54.81 |
Price Performance
Historical ComparisonAbout BMI Badger Meter Inc.
Badger Meter is a provider of water management solutions. The company's solutions encompass measurement and control hardware, connectivity and communication, data visualization and software. Badger Meter has global operations, with the vast majority of revenue derived from the US.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).